Hefei Meiya Optoelectronic Technology (SZ:002690) ZHONGTAI SECURITIES·2026-03-31 08:44Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative performance increase of over 15% against the benchmark index in the next 6 to 12 months [17]. Core Insights - The company reported a revenue of 2.407 billion yuan for 2025, reflecting a year-on-year growth of 4.16%, and a net profit attributable to shareholders of 719 million yuan, up 10.77% year-on-year [4][5]. - The company has shown significant improvement in profitability, with a gross margin of 53.92%, an increase of 3.49 percentage points year-on-year, and a net profit margin of 29.88%, up 1.79 percentage points year-on-year [7]. - The company is focusing on technological innovation in the dental medical field, launching new products and applications, and is optimistic about future growth despite current market challenges [12]. Financial Performance Summary - Revenue and Profit Forecast: - 2024A: Revenue of 2.311 billion yuan, net profit of 649 million yuan - 2025A: Revenue of 2.407 billion yuan, net profit of 719 million yuan - 2026E: Revenue of 2.749 billion yuan, net profit of 846 million yuan - 2027E: Revenue of 3.112 billion yuan, net profit of 981 million yuan - 2028E: Revenue of 3.485 billion yuan, net profit of 1.127 billion yuan [3][14]. - Growth Rates: - Revenue growth rates are projected at -5% for 2024, 4% for 2025, and 14% for 2026, with net profit growth rates at -13% for 2024, 11% for 2025, and 18% for 2026 [3][14]. Operational Efficiency - The company has improved its inventory turnover days to 97.28 days, a decrease of 12.28 days year-on-year, and accounts receivable turnover days to 63.33 days, down 16.41 days year-on-year, indicating better sales channel optimization and cost control [8]. - The company’s R&D investment reached 164 million yuan in 2025, accounting for 6.81% of revenue, with a slight decrease of 0.09 percentage points year-on-year [8]. Market Position and Product Development - The color sorting machine segment continues to grow steadily, with revenue reaching 1.753 billion yuan in 2025, an increase of 8.05% year-on-year, and a gross margin of 54.26%, up 4.62 percentage points [9]. - The company is a pioneer in the domestic color sorting industry, focusing on innovation and expanding its product applications across various sectors [9]. Future Outlook - The company is optimistic about the dental medical market despite current downturns, with a projected revenue of 454 million yuan from medical equipment in 2025, although this represents a decline of 9.75% year-on-year [12]. - The introduction of the "Meiya Dental Health Digital Cloud Platform" aims to enhance operational efficiency and is expected to contribute to revenue growth as AI applications develop [13].